← back to search

Denise Bernhardt

TUM Klinikum · DE
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Radiomics and Machine Learning in Medical Imaging, and Advanced Radiotherapy Techniques.
h-index
30
citations
2,682
works
222
NIH funding
primary concept
email

Recent publications

Hypofractionated stereotactic radiotherapy versus whole-brain radiotherapy following brain metastasis resection: Results of the ESTRON randomized phase 2 trial
Neuro-Oncology 2025cited by 3position: middledoi
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma – Results from a large multicenter analysis of the German Society of Radiation Oncology’s Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)
Radiotherapy and Oncology 2025cited by 1position: middledoi
NSCLC mit synchroner Oligometastasierung zum Zeitpunkt Erstdiagnose. Einfluss unterschiedlicher Systemtherapien auf die Prognose. Eine BZKF-Analyse.
Pneumologie 2025cited by 0position: middledoi
NSCLC mit synchroner Oligometastasierung zum Zeitpunkt Erstdiagnose. Einfluss von System- und Lokaltherapie auf die Prognose. Eine BZKF-Analyse
Pneumologie 2025cited by 0position: middledoi
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study
The Lancet Oncology 2024cited by 39position: middledoi
Stereotactic radiosurgery for 1–10 brain metastases to avoid whole-brain radiotherapy: Results of the CYBER-SPACE randomized phase 2 trial
Neuro-Oncology 2024cited by 17position: middledoi
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Neuro-Oncology 2024cited by 16position: middledoi
Imaging meningioma biology: Machine learning predicts integrated risk score in WHO grade 2/3 meningioma
Neuro-Oncology Advances 2024cited by 9position: middledoi
CT-based radiomics for predicting breast cancer radiotherapy side effects
Scientific Reports 2024cited by 9position: middledoi
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers
Journal of Neuro-Oncology 2024cited by 2position: middledoi
Pneumonitis after normofractionated radioimmunotherapy: a method for dosimetric evaluation
Radiation Oncology 2024cited by 1position: middledoi
Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study
Clinical & Experimental Metastasis 2024cited by 1position: middledoi
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)
JNCI Journal of the National Cancer Institute 2023cited by 22position: middledoi
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
European Journal of Nuclear Medicine and Molecular Imaging 2023cited by 20position: middledoi
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial
Neuro-Oncology 2023cited by 18position: middledoi
Identifying core MRI sequences for reliable automatic brain metastasis segmentation
Radiotherapy and Oncology 2023cited by 15position: middledoi
The importance of planning CT-based imaging features for machine learning-based prediction of pain response
Scientific Reports 2023cited by 10position: middledoi
Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy for Patients with 1-10 Brain Metastases from Small Cell Lung Cancer: Results of the Randomized ENCEPHALON (ARO 2018-9) Trial
International Journal of Radiation Oncology*Biology*Physics 2023cited by 9position: firstdoi
Radiotherapy concepts for spinal metastases—results from an online survey among radiation oncologists of the German Society for Radiation Oncology
Strahlentherapie und Onkologie 2023cited by 5position: middledoi
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
Clinical and Translational Radiation Oncology 2023cited by 2position: middledoi
RADT-40. FINAL RESULTS OF THE PROSPECTIVE PHASE 2 MARCIE TRIAL: EFFICACY AND TOXICITY OF POSTOPERATIVE BIMODAL RADIOTHERAPY WITH C12-BOOST IN PATIENTS WITH ATYPICAL MENINGIOMAS FOLLOWING SUBTOTAL RESECTION
Neuro-Oncology 2023cited by 1position: middledoi
Identifying core MRI sequences for reliable automatic brain metastasis segmentation
medRxiv 2023cited by 1position: middledoi
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis
Strahlentherapie und Onkologie 2022cited by 46position: firstdoi
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment
Strahlentherapie und Onkologie 2022cited by 41position: firstdoi
Automated detection and quantification of brain metastases on clinical MRI data using artificial neural networks
Neuro-Oncology Advances 2022cited by 31position: middledoi
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
European Journal of Nuclear Medicine and Molecular Imaging 2022cited by 30position: middledoi
Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter study
Radiotherapy and Oncology 2022cited by 30position: middledoi
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma
Acta Neuropathologica 2022cited by 14position: middledoi
Stereotactic radiotherapy of brain metastases: clinical impact of three-dimensional SPACE imaging for 3T-MRI-based treatment planning
Strahlentherapie und Onkologie 2022cited by 11position: middledoi
Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy
Cancers 2022cited by 9position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jürgen Debus · NYU Langone Health61 papers (2015–2024)Stefan Rieken · University Medical Center51 papers (2015–2025)Sebastian Adeberg · Goethe University Frankfurt48 papers (2015–2025)Laila König · Heidelberg University25 papers (2016–2025)Kristin Lang · Heidelberg University22 papers (2017–2025)Stephanie E. Combs · Brooke Army Medical Center22 papers (2015–2025)Rami A. El Shafie · University Medical Center21 papers (2017–2025)Klaus Herfarth · Universitätsklinik für Strahlentherapie18 papers (2016–2023)Semi Harrabi · Heidelberg University17 papers (2015–2022)Juliane Hörner‐Rieber · German Cancer Research Center15 papers (2017–2024)Wolfgang Wick · Heidelberger Institut für Radioonkologie12 papers (2015–2023)Michael Thomas · Barwon Health12 papers (2016–2024)Andreas Unterberg · Heidelberg University11 papers (2016–2023)Sati Akbaba · German Cancer Research Center11 papers (2019–2021)Daniela Schmitt · University Medical Center11 papers (2018–2025)Angela Paul · Heidelberg University10 papers (2017–2025)Nina Bougatf · German Cancer Research Center10 papers (2016–2021)Farastuk Bozorgmehr · University Hospital Heidelberg10 papers (2016–2025)Thomas Held · Heidelberg University10 papers (2018–2021)Peter K. Plinkert · Heidelberg University9 papers (2018–2022)